Growing Inclination of Next-generation Sequencing: Emerging Clinical Applications and Global Markets
Press Release – 11
Jan 2019
Research
and Development News
--
.
.
Latest
Update
"Next-generation Sequencing: Emerging Clinical Applications and
Global Markets Update 2018"
with Industries Survey | Global Current Growth and Future.
'
'
Report Includes
- An overview of the global market for next-generation sequencing and its emerging clinical applications
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
(The next generation sequencing market reached $231.7 million in 2012. The market is expected to reach $510.7 million in 2013 and $7.6 billion in 2018 for a compound annual growth rate (CAGR) of 71.6%.)
- Examination of the sequencing industry structure for the key market segments, as well as strategic alliances and acquisitions, as well as evaluations of sequencing patents
- Discussion of the strategies of the main companies in the market
- Comprehensive company profiles of major players in the field
'
'
The global
clinical next-generation sequencing (NGS) market reached $2.7 billion
in 2016. This market is expected to grow at a compound annual growth
rate (CAGR) of 27%, from nearly $3.2 billion in 2017 to $10.5 billion
by 2022.
Report Scope
The scope of the report includes clinical NGS
technologies, applications, industries, initiatives, patents and
companies. The markets for NGS-based diagnostics are given for
the years 2012, 2013 and 2018.
This report reviews the main sequencing
technologies and explains why genetic variation is important in
clinical testing. It then discusses some of the top research
initiatives that are contributing to clinical NGS applications.
Market driving forces are also discussed.
The report examines the markets by test
complexity, indication and test purpose. Test complexity refers
to the multiplexing (e.g., the number of genes covered) and coverage
(e.g., the extent to which the genome is covered) of the test.
Examining the market by test complexity provides valuable insight
into which products (e.g., sample preparation, NGS instrument,
informatics) will be in demand in the future.
(Non-cancer
applications as a segment should reach $2.3 billion in 2017 to $6.4
billion by 2020, at a CAGR of 22.3% from 2017 to 2022.)
– For
Other Requirement and Enquiry_
https://www.researchmoz.us/enquiry.php?type=E&repid=1377182
'
'
The report
provides market data and forecasts for NGS diagnostics by specific
applications, including those for cancer, rare diseases, common
diseases, and pre- and post-natal screening.
- Specific geographic markets are discussed,
including North America, Europe, China, Japan and the rest of the
world.
- Market data covers the years 2012, 2013 and
2018.
- Industry sectors analyzed include NGS
instruments, target enrichment, informatics, clinical laboratories
and the prenatal screening industry.
- More than 110 companies in the clinical NGS
industry are profiled in this report.
- BCC Research provides a summary of the main
industry acquisitions and strategic alliances from 2011 through 2013,
including key alliance trends.
(Cancer
applications as a segment should reach $838.8 million in 2017 to
nearly $4.1 billion by 2022, at a CAGR of 37.3% from 2017 to 2022)
Continue.....
– More
Clear Details get Full Table of Contents_
https://www.researchmoz.us/next-generation-sequencing-emerging-clinical-applications-and-global-markets-report.html/toc
About
Researchmoz,
ResearchMoz
is the world’s fastest growing collection of market research
reports worldwide. Our database is composed of current market studies
from over 100 featured publishers worldwide. Our market research
databases integrate statistics with analysis from global, regional,
country and company perspectives. ResearchMoz’s service portfolio
also includes value-added services such as market research
customization, competitive landscaping, and in-depth surveys,
delivered by a team of experienced Research
Coordinators.
--Researchmoz Global Pvt. Ltd.--
--Researchmoz Global Pvt. Ltd.--
Mr.
Nachiket G.
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074www.researchmoz.us
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074www.researchmoz.us
Comments
Post a Comment